UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue
Veracyte, Inc. (NASDAQ:VCYT) ranks among the best innovative stocks to buy according to Wall Street analysts. On January 12, UBS…
Tag: Reaffirmed
XRP Legal Status Reaffirmed as SEC Remains Blocked From Core Security Claim
XRP’s legal standing under U.S. securities law is considered settled after the Ripple ruling, but renewed scrutiny of dropped crypto…
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat
GeneDx Holdings Corp. (NASDAQ:WGS) is one of the best digital health stocks to buy now. On October 29, 2025, Guggenheim…
Mizuho Raised Waystar Target to $50, Reaffirmed Outperform After Q3 Strength
Waystar Holding Corp. (NASDAQ:WAY) is one of the best digital health stocks to buy now. On October 30, 2025, following…
Oracle (ORCL) Price Target Reaffirmed at $350 as Analysts Stay Bullish
Oracle Corporation (NYSE:ORCL) is one of the Buzzing AI Stocks on Wall Street. On September 23, KeyBanc analyst Jackson Ader reiterated…
Tesla (TSLA) Stock Reaffirmed at Peer Perform as Analyst Highlights Energy Strength
Tesla, Inc. (NASDAQ:TSLA) is one of the AI Stocks on Wall Street’s Radar. One of the biggest analyst calls on September 11…
CrowdStrike (CRWD) Stock Reaffirmed Overweight by Wells Fargo
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is one of the Trending AI Stocks on Wall Street. On August 28, Wells Fargo reiterated the…